CMS Finalizes Medicare Rx Regs; Rebate Rules Await Further Guidance
Executive Summary
The Centers for Medicare & Medicaid Services will issue a guidance on how Part D plan sponsors should report rebates following the publication of the final implementing regulations
You may also be interested in...
Medicare Rx Risk-Sharing Deals Not Covered By Safe Harbors, Attorneys Say
Drug manufacturers and Medicare Part D drug plan sponsors may be misinterpreting the Medicare Modernization Act as they form risk-sharing arrangements, Sidley Austin Brown & Wood Partner William Sarraille told the Pharmaceutical Compliance Summit March 30 in Philadelphia
Medicare Rx Risk-Sharing Deals Not Covered By Safe Harbors, Attorneys Say
Drug manufacturers and Medicare Part D drug plan sponsors may be misinterpreting the Medicare Modernization Act as they form risk-sharing arrangements, Sidley Austin Brown & Wood Partner William Sarraille told the Pharmaceutical Compliance Summit March 30 in Philadelphia
New York EPIC Rx Plan Will Wrap Around Part D; Model For Other States?
New York plans to retain its state pharmaceutical assistance program once the Medicare Part D drug benefit goes into effect, EPIC Director Julie Naglieri said during the NACDS Medicare Prescription Drugs & Reform conference in Baltimore March 3